The macrophage-specific serum marker, soluble CD163, is increased in obesity and reduced after dietary-induced weight loss

Obesity

Volumn 21, Issue 12, 2013, Pages 2437-2443

  Fjeldborg, Karen ^a   Christiansen, Tore ^a   Bennetzen, Marianne ^a   Møller, Holger J ^a   Pedersen, Steen B ^a   Richelsen, Bjørn ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CD163 ANTIGEN; LEPTIN;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CALORIC RESTRICTION; CONTROLLED STUDY; DISEASE ASSOCIATION; EXERCISE INTENSITY; FEMALE; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; INSULIN RESISTANCE; INVESTIGATIVE PROCEDURES; MAJOR CLINICAL STUDY; MALE; OBESITY; PHYSICAL ACTIVITY; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

ADIPONECTIN; ADULT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALORIC RESTRICTION; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN RESISTANCE; LEPTIN; LINEAR MODELS; MACROPHAGES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECEPTORS, CELL SURFACE; WAIST CIRCUMFERENCE; WEIGHT LOSS;

EID: 84889644143     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20376     Document Type: Article

References (30)

1. Stefan N, Kantartzis K, Machann J, et al. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 2008; 168: 1609-1616.
2. Barbarroja N, Lopez-Pedrera R, Mayas MD, et al. The obese healthy paradox: Is inflammation the answer? Biochem J 2010; 430: 141-149.
3. Dandona P, Aljada A, Bandyopadhyay A,. Inflammation: The link between insulin resistance, obesity and diabetes. Trends Immunol 2004; 25: 4-7.
4. Bruun JM, Lihn AS, Madan AK, et al. Higher production of IL-8 in visceral vs. subcutaneous adipose tissue. Implication of nonadipose cells in adipose tissue. Am J Physiol Endocrinol Metab 2004; 286: E8-E13.
5. Bruun JM, Lihn AS, Pedersen SB, Richelsen B,. Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): Implication of macrophages resident in the AT. J Clin Endocrinol Metab 2005; 90: 2282-2289.
6. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr., Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-1808.
7. Christiansen T, Richelsen B, Bruun JM,. Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects. Int J Obes (Lond) 2005; 29: 146-150.
8. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G,. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 2001; 280: E745-E751.
9. Moller HJ, Aerts H, Gronbaek H, et al. Soluble CD163: A marker molecule for monocyte/macrophage activity in disease. Scand J Clin Lab Invest Suppl 2002; 237: 29-33.
10. Moller HJ, Peterslund NA, Graversen JH, Moestrup SK,. Identification of the hemoglobin scavenger receptor/CD163 as a natural soluble protein in plasma. Blood 2002; 99: 378-380.
11. Moestrup SK, Moller HJ,. CD163: A regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response. Ann Med 2004; 36: 347-354.
12. Moller HJ,. Soluble CD163. Scand J Clin Lab Invest 2012; 72: 1-13.
13. Kneidl J, Loffler B, Erat MC, et al. Soluble CD163 promotes recognition, phagocytosis and killing of Staphylococcus aureus via binding of specific fibronectin peptides. Cell Microbiol 2012; 14: 914-936.
14. Etzerodt A, Maniecki MB, Moller K, Moller HJ, Moestrup SK,. Tumor necrosis factor alpha-converting enzyme (TACE/ADAM17) mediates ectodomain shedding of the scavenger receptor CD163. J Leukoc Biol 2010; 88: 1201-1205.
15. Moller HJ, Frikke-Schmidt R, Moestrup SK, Nordestgaard BG, Tybjaerg-Hansen A,. Serum soluble CD163 predicts risk of type 2 diabetes in the general population. Clin Chem 2011; 57: 291-297.
16. Axelsson J, Moller HJ, Witasp A, et al. Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD. Am J Kidney Dis 2006; 48: 916-925.
17. Sporrer D, Weber M, Wanninger J, et al. Adiponectin downregulates CD163 whose cellular and soluble forms are elevated in obesity. Eur J Clin Invest 2009; 39: 671-679.
18. Zanni MV, Burdo TH, Makimura H, Williams KC, Grinspoon SK,. Relationship between monocyte/macrophage activation marker soluble CD163 and insulin resistance in obese and normal-weight subjects. Clin Endocrinol (Oxf) 2012; 77: 385-390.
19. Parkner T, Sorensen LP, Nielsen AR, et al. Soluble CD163: A biomarker linking macrophages and insulin resistance. Diabetologia 2012; 55: 1856-1862.
20. Shakeri-Manesch S, Zeyda M, Huber J, Ludvik B, Prager G, Stulnig TM,. Diminished upregulation of visceral adipose heme oxygenase-1 correlates with waist-to-hip ratio and insulin resistance. Int J Obes (Lond) 2009; 33: 1257-1264.
21. Finucane FM, Luan J, Wareham NJ, et al. Correlation of the leptin:adiponectin ratio with measures of insulin resistance in non-diabetic individuals. Diabetologia 2009; 52: 2345-2349.
22. Bennetzen MF,. Investigations of the endocannabinoid system in adipose tissue: Effects of obesity/weight loss and treatment options. Dan Med Bull 2011; 58: B4269.
23. Christiansen T, Paulsen SK, Bruun JM, et al. Comparable reduction of the visceral adipose tissue depot after a diet-induced weight loss with or without aerobic exercise in obese subjects: A 12-week randomized intervention study. Eur J Endocrinol 2009; 160: 759-767.
24. Moller HJ, Hald K, Moestrup SK,. Characterization of an enzyme-linked immunosorbent assay for soluble CD163. Scand J Clin Lab Invest 2002; 62: 293-299.
25. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC,. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
26. Volund A,. Conversion of insulin units to SI units. Am J Clin Nutr 1993; 58: 714-715.
27. Inadera H,. The usefulness of circulating adipokine levels for the assessment of obesity-related health problems. Int J Med Sci 2008; 5: 248-262.
28. Hajer GR, Van Haeften TW, Visseren FLJ,. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J 2008; 29: 2959-2971.
29. Oberhauser F, Schulte DM, Faust M, et al. Weight loss due to a very low calorie diet differentially affects insulin sensitivity and interleukin-6 serum levels in nondiabetic obese human subjects. Horm Metab Res 2012; 44: 465-470.
30. Phillips LK, Prins JB,. The link between abdominal obesity and the metabolic syndrome. Curr Hypertens Rep 2008; 10: 156-164.